ヒト臓器の市場- 世界の産業規模、シェア、動向、機会、予測、供給源別、臓器タイプ別、地域別、競争別、2020-2030F

ヒト臓器の世界市場規模は2024年に5億1,024万米ドル、予測期間中のCAGRは4.15%で2030年には6億4,379万米ドルに達すると予測されています。

世界のヒト臓器の市場は、バイオテクノロジーの進歩、個別化医療に対する需要の増加、疾患モデリングと創薬に焦点を当てた研究活動の増加により、大きな成長を遂げています。幹細胞から培養されたヒト臓器の3次元ミニチュア版であるオルガノイドは、従来の方法と比較して、より精密で倫理的に持続可能な方法でヒトの生物学を研究するための革新的なプラットフォームを提供します。この市場は、製薬、バイオテクノロジー、学術の各分野で牽引力を増しており、調査、薬剤試験、再生医療に有望な道を提供しています。

市場促進要因

ヘルスケア産業の成長

主な市場課題

開発・研究コストの高さ

主な市場動向

創薬と検査におけるアプリケーションの増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のヒト臓器市場に与える影響

第5章 世界のヒト臓器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 由来別（成体幹細胞、人工多能性幹細胞、胚性幹細胞、その他）
  • 臓器別（胃モデル、腸モデル、肝臓モデル、膵臓モデル、肺モデル、脳モデル、腎臓モデル、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のヒト臓器市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のヒト臓器市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のヒト臓器市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のヒト臓器市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのヒト臓器市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 世界のヒト臓器市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• アメリカンタイプカルチャーコレクション（ATCC）
• 事業概要
• 会社概要
• 製品とサービス
• 財務状況（報告通り）
• 最近の動向
• 主要人物の詳細
• SWOT分析
• サーモフィッシャーサイエンティフィック株式会社
• STEMCELL Technologies Canada Inc.
• メルクKGaA
• コーニングインコーポレーテッド
• バイオテクネ株式会社
• アクロバイオシステムズ株式会社
• AMSバイオテクノロジー（欧州）株式会社
• 株式会社Qkine
• PRIMACYT細胞培養テクノロジー株式会社

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Human Organoids Market was valued at USD 510.24 Million in 2024 and is expected to reach USD 643.79 Million by 2030 with a CAGR of 4.15% during the forecast period. The global human organoids market is witnessing significant growth, driven by advancements in biotechnology, increasing demand for personalized medicine, and a rise in research activities focusing on disease modeling and drug discovery. Organoids, which are three-dimensional, miniature versions of human organs grown from stem cells, offer an innovative platform for studying human biology in a more precise and ethically sustainable way compared to traditional methods. This market is gaining traction across pharmaceutical, biotechnology, and academic sectors, offering promising avenues for research, drug testing, and regenerative medicine.

Key Market Drivers

Growth in Healthcare Industry

The growth of the global healthcare industry is a key driver of the human organoids market, propelling advancements in research, personalized medicine, and drug development. The healthcare industry ranks among the largest and most rapidly expanding sectors globally. In many developed countries, healthcare expenditures exceed 10 percent of the gross domestic product (GDP), representing a substantial portion of their economies. In the United States, healthcare spending increased by 2.7 percent in 2021, totaling USD 4.3 trillion, or USD 12,914 per capita. Healthcare spending also accounted for 18.3 percent of the nation's GDP. As healthcare systems worldwide continue to expand and evolve, there is a growing emphasis on innovative solutions to enhance the understanding of human biology, improve disease modeling, and accelerate the development of novel therapeutics. Human organoids-3D structures grown from stem cells that mimic the architecture and functionality of human organs-are becoming a critical tool in these advancements.

Key Market Challenges

High Costs of Development and Research

One of the key challenges facing the global human organoids market is the high costs associated with the development and research of these advanced biological models. The process of creating organoids, which involves cultivating stem cells to mimic the structure and function of human organs, requires cutting-edge technology, specialized expertise, and extensive laboratory resources. These factors contribute to significant upfront investment and ongoing operational expenses, which can hinder the widespread adoption and scalability of organoid technology.

The development of human organoids requires sophisticated equipment such as bioreactors, 3D cell culture systems, and precise imaging technologies, all of which are expensive to acquire and maintain. In addition, the cultivation of high-quality stem cells and the optimization of growth conditions to produce functional organoids are complex tasks that demand highly skilled personnel. Hiring and training researchers with the expertise to work with these intricate models further adds to the cost burden.

Key Market Trends

Rising Applications in Drug Discovery and Testing

The rising applications of human organoids in drug discovery and testing are emerging as a significant trend in the global human organoids market, transforming the way pharmaceutical research is conducted. Human organoids, which are lab-grown 3D structures that mimic the physiological and functional properties of human organs, offer a highly accurate platform for studying human diseases, testing new drugs, and predicting treatment outcomes. This innovative technology is gaining widespread adoption in the pharmaceutical industry, driven by the need for more efficient, cost-effective, and reliable drug development processes. In 2020, 53 new medicines were introduced, and over 9,000 compounds are currently in various stages of development worldwide. The research-driven biopharmaceutical sector is estimated to have invested USD 198 billion globally in R&D during that year.

Key Market Players

• American Type Culture Collection (ATCC)
• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Canada Inc.
• Merck KGaA
• Corning Incorporated
• Bio-Techne Corporation
• ACROBIOSYSTEMS INC.
• AMS Biotechnology (Europe) Ltd
• Qkine Ltd.
• PRIMACYT Cell Culture Technology GmbH

Report Scope

In this report, the Global Human Organoids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Organoids Market, By Source:

• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells
• Others

Human Organoids Market, By Organ Type:

• Stomach Models
• Intestine Models
• Liver Models
• Pancreatic Models
• Lung Models
• Brain Models
• Kidney Models
• Others

Human Organoids Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Organoids Market.

Available Customizations:

Global Human Organoids Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Human Organoids Market

5. Global Human Organoids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others)
  • 5.2.2. By Organ Type (Stomach Models, Intestine Models, Liver Models, Pancreatic Models, Lung Models, Brain Models, Kidney Models, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Human Organoids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Source
  • 6.2.2. By Organ Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Human Organoids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Source
      • 6.3.1.2.2. By Organ Type
  • 6.3.2. Mexico Human Organoids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Source
      • 6.3.2.2.2. By Organ Type
  • 6.3.3. Canada Human Organoids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Source
      • 6.3.3.2.2. By Organ Type

7. Europe Human Organoids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Source
  • 7.2.2. By Organ Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Human Organoids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Source
      • 7.3.1.2.2. By Organ Type
  • 7.3.2. Germany Human Organoids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Source
      • 7.3.2.2.2. By Organ Type
  • 7.3.3. United Kingdom Human Organoids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Source
      • 7.3.3.2.2. By Organ Type
  • 7.3.4. Italy Human Organoids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Source
      • 7.3.4.2.2. By Organ Type
  • 7.3.5. Spain Human Organoids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Source
      • 7.3.5.2.2. By Organ Type

8. Asia Pacific Human Organoids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Source
  • 8.2.2. By Organ Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Human Organoids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Source
      • 8.3.1.2.2. By Organ Type
  • 8.3.2. India Human Organoids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Source
      • 8.3.2.2.2. By Organ Type
  • 8.3.3. South Korea Human Organoids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Source
      • 8.3.3.2.2. By Organ Type
  • 8.3.4. Japan Human Organoids Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Source
      • 8.3.4.2.2. By Organ Type
  • 8.3.5. Australia Human Organoids Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Source
      • 8.3.5.2.2. By Organ Type

9. South America Human Organoids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Source
  • 9.2.2. By Organ Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Human Organoids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Source
      • 9.3.1.2.2. By Organ Type
  • 9.3.2. Argentina Human Organoids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Source
      • 9.3.2.2.2. By Organ Type
  • 9.3.3. Colombia Human Organoids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Source
      • 9.3.3.2.2. By Organ Type

10. Middle East and Africa Human Organoids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Source
  • 10.2.2. By Organ Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Human Organoids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Source
      • 10.3.1.2.2. By Organ Type
  • 10.3.2. Saudi Arabia Human Organoids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Source
      • 10.3.2.2.2. By Organ Type
  • 10.3.3. UAE Human Organoids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Source
      • 10.3.3.2.2. By Organ Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Human Organoids Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1.1. American Type Culture Collection (ATCC)
• 15.1.2. Business Overview
• 15.1.3. Company Snapshot
• 15.1.4. Products & Services
• 15.1.5. Financials (As Reported)
• 15.1.6. Recent Developments
• 15.1.7. Key Personnel Details
• 15.1.8. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. STEMCELL Technologies Canada Inc.
• 15.4. Merck KGaA
• 15.5. Corning Incorporated
• 15.6. Bio-Techne Corporation
• 15.7. ACROBIOSYSTEMS INC.
• 15.8. AMS Biotechnology (Europe) Ltd
• 15.9. Qkine Ltd.
• 15.10. PRIMACYT Cell Culture Technology GmbH

16. Strategic Recommendations

17. About Us & Disclaimer